Send us Feedback

Amex Telecomunications Index (PHN)

QUOTE AND NEWS
Polski Holding Nieruchomości Newly Listed On WSE - It Is The 439th Company Listed And The Second New Listing In 2013 On The Warsaw Stock Exchange’s Main Market - PHN Is The First State-Owned Company To Be Newly Listed On The WSE This Year
Mondo Visione  Feb 13  Comment 
Polski Holding Nieruchomości (PHN) has been newly listed on the Warsaw Stock Exchange on 13 February 2013. PHN will join a group of property developers listed on the WSE and the company’s shares will be included in the portfolios of indices...
Depomed Files Suit Against The FDA Seeking Grant Of Orphan Drug Exclusivity For Gralise
Benzinga  Sep 25  Comment 
Depomed (Nasdaq: DEPO) today announced that it has filed an action in federal district court for the District of Columbia against the Food and Drug Administration, seeking an order requiring the FDA to grant Gralise® (gabapentin) Orphan Drug...
From Earlier, GSK and XenoPort Receive FDA Approval for Horizant® for Postherpetic Neuralgia
Benzinga  Jun 7  Comment 
GlaxoSmithKline plc (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant® (gabapentin enacarbil) Extended-Release Tablets for the management of...
Polish PHN IPO may stumble on complexity, market woes
Reuters  Apr 16  Comment 
The flotation of state-owned PHN, a centrepiece of Poland's 10 billion zlotys ($3.1 billion) privatisation plan for 2012, may fall through on the hastily-forged real...
Depomed Announces Acceptance of New Drug Application for Investigational Postherpetic Neuralgia Treatment DM-1796
Globe Newswire  Jun 7  Comment 
MENLO PARK, Calif., June 7, 2010 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that the New Drug Application (NDA) for DM-1796 was accepted by the U.S. Food and Drug Administration (FDA) for the management of postherpetic neuralgia
Glaxo reports positive Phase 2 PHN drug study
MarketWatch  Oct 5  Comment 
GlaxoSmithKline and XenoPort said a Phase II trial evaluating GSK1838262/XP13512 in adult patients with neuropathic pain associated with post-herpetic neuralgia demonstrated a statistically significant improvement over 1200 mg/day of GSK1838262...
Promising pain data fuels spike in XenoPort shares
FierceBiotech  Sep 17  Comment 
Shares of XenoPort barreled ahead 29 percent on Thursday after researchers reported that its neuropathic pain drug--which is partnered with GlaxoSmithKline--hit its primary endpoint of reducing the intensity of pain in a Phase IIb trial. The...




RELATED WIKI ARTICLES

Related Articles

more ▼WIKI ANALYSIS
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_1/mediawiki/images/a/ad/Indices.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_1/mediawiki/images/a/ad/Indices.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_1/mediawiki/images/thumb/a/ad/Indices.png/40px-Indices.png' @ convert.c/ConvertImageCommand/2800.
 This article describes an index that measures the performance of an exchange, industry or a geographic region. View articles referencing this index.
 
Retrieved from "http://www.wikinvest.com/index/Amex_Telecomunications_Index_(PHN)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki